BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4340534)

  • 1. Rat adrenal cyclic nucleotide-phosphodiesterase; inhibition by drugs known to affect steroidogenesis.
    Klotz U; Vapaatalo H; Stock K
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(4):376-85. PubMed ID: 4340534
    [No Abstract]   [Full Text] [Related]  

  • 2. Steroidogenesis in isolated adrenal cells of rat. II. Effect of caffeine on ACTH and cyclic nucleotide-induced steroidogenesis and its relation to cyclic nucleotide phosphodiesterase (PDE).
    Kitabchi AE; Wilson DB; Sharma RK
    Biochem Biophys Res Commun; 1971 Aug; 44(4):898-904. PubMed ID: 4331040
    [No Abstract]   [Full Text] [Related]  

  • 3. Rat diaphragm cyclic nucleotide-phosphodiesterase: influence of drugs affecting skeletal muscle contractility.
    Klotz U; Vapaatalo H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(4):373-82. PubMed ID: 4375256
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on adrenocortical carcinoma of rat cyclic nucleotide phosphodiesterase activities.
    Sharma RK
    Cancer Res; 1972 Aug; 32(8):1734-6. PubMed ID: 4339750
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclic nucleotide phosphodiesterase inhibition and vascular smooth muscle relaxation.
    Lugnier C; Bertrand Y; Stoclet JC
    Eur J Pharmacol; 1972 Jul; 19(1):134-6. PubMed ID: 4340226
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of phosphodiesterase inhibitors on cyclic AMP levels and on lipolysis.
    Beavo JA; Rogers NL; Crofford OB; Baird CE; Hardman JG; Sutherland EW; Newman EV
    Ann N Y Acad Sci; 1971 Dec; 185():129-36. PubMed ID: 4330487
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of cyclic-3',5'-nucleotide-phosphodiesterase as a possible mode of action of papaverine and similarly acting drugs.
    Kukovetz WR; Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 267(2):189-94. PubMed ID: 4320455
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic nucleotide phosphodiesterases: properties, activators, inhibitors, structure--activity relationships, and possible role in drug development.
    Samir Amer M; Kreighbaum WE
    J Pharm Sci; 1975 Jan; 64(1):1-37. PubMed ID: 166154
    [No Abstract]   [Full Text] [Related]  

  • 9. Actions of various cyclic nucleotides, nucleosides and purine bases on the synthesis of corticosterone in vitro.
    Vapaatalo H; Bieck P; Westermann E
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(4):435-43. PubMed ID: 4348046
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroidogenic and glycolytic responses to nucleotides, nucleosides and steroids in rodent adrenal glands: opposing, species-dependent effects of cyclic GMP.
    Hum WT; Barta-Bartova A; Birmingham MK
    J Endocrinol; 1981 Dec; 91(3):447-56. PubMed ID: 6276485
    [No Abstract]   [Full Text] [Related]  

  • 11. Phosphodiesterases from porcine coronary arteries: inhibition of separated forms by xanthines, papaverine, and cyclic nucleotides.
    Wells JN; Wu YJ; Baird CE; Hardman JG
    Mol Pharmacol; 1975 Nov; 11(6):775-83. PubMed ID: 173982
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclic nucleotide phosphodiesterase: high activity in a mammalian photoreceptor.
    Pannbacker RG; Fleischman DE; Reed DW
    Science; 1972 Feb; 175(4023):757-8. PubMed ID: 4333398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and inhibition of lipolysis in isolated fat cells by various inhibitors of cyclic AMP phosphodiesterase.
    Schwabe U; Berndt S; Ebert R
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):62-74. PubMed ID: 4338396
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroblastoma clones: prostaglandin versus dibutyryl cyclic AMP, 8-benzylthio-cyclic AMP, phosphodiesterase inhibitors and x-rays.
    Prasad KN
    Proc Soc Exp Biol Med; 1972 May; 140(1):126-9. PubMed ID: 4338181
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effects of angiotensin and ACTH on cyclic AMP and steroidogenesis in isolated bovine adrenal cells.
    Peytremann A; Nicholson WE; Brown RD; Liddle GW; Hardman JG
    J Clin Invest; 1973 Apr; 52(4):835-42. PubMed ID: 4348344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance of a separated form of canine ureteral phosphodiesterase activity to inhibition by xanthines and papaverine.
    Weiss RM; Hardman JG; Wells JN
    Biochem Pharmacol; 1981 Aug; 30(16):2371-4. PubMed ID: 6271142
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of cyclic nucleotides on activity of cyclic 3',5'-adenosine monophosphate phosphodiesterase.
    Harris DN; Chasin M; Phillips MB; Goldenberg H; Samaniego S; Hess SM
    Biochem Pharmacol; 1973 Jan; 22(2):221-8. PubMed ID: 4357795
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of methylxanthines on adenosine 3',5'-monophosphate and corticosterone in the rat adrenal.
    Peytremann A; Nicholson WE; Liddle GW; Hardman JG; Sutherland EW
    Endocrinology; 1973 Feb; 92(2):525-30. PubMed ID: 4345537
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets.
    Mills DC; Smith JB
    Biochem J; 1971 Jan; 121(2):185-96. PubMed ID: 4330088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphodiesterase activity of rat and human adipose tissue.
    Solomon SS
    J Lab Clin Med; 1972 Apr; 79(4):598-610. PubMed ID: 4336560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.